In addition, a novel lincRNA termed "UCC" was found to be highly expressed in human CRC tissues and cell lines and to facilitate CRC progression by acting as a sponge for miR-143. 8 The expression of lnc-sox5 is significantly higher in CRC and regulates CRC tumourigenesis by unbalancing the tumour microenvironment. 9 A long intergenic non-coding RNA called LINC00312, encoded in chromosomal region 3p25.3, has been reported to be a novel tumour suppressor gene in several cancers, 10-12 but its role and mechanism of action in CRC development remain to be elucidated.
| INTRODUCTION
Colorectal cancer (CRC) is ranked as the third most prevalent cancer and occurs in both men and women, with~700 000 deaths per year.
1,2 Therapeutic methods including surgical resection, chemotherapy and radiotherapy have been widely used but poorly improved as CRC treatments. 3 Therefore, exploring the molecular mechanisms such as inactivation of tumour suppressor genes might provide significant insights into adequate improvement of diagnosis and management of CRC.
By means of next-generation sequencing, long non-coding RNAs (lncRNAs) longer than 200 nt have been identified. Accumulating evidence regarding lncRNAs has shown their possible roles in various cancers, including CRC. [4] [5] [6] The latest study revealed that lncRNA CRNDE may promote CRC cell proliferation and chemoresistance by modulating miR-181a-5p and the Wnt/β-catenin signalling pathway. 7 In addition, a novel lincRNA termed "UCC" was found to be highly expressed in human CRC tissues and cell lines and to facilitate CRC progression by acting as a sponge for miR-143. 8 The expression of lnc-sox5 is significantly higher in CRC and regulates CRC tumourigenesis by unbalancing the tumour microenvironment. 9 A long intergenic non-coding RNA called LINC00312, encoded in chromosomal region 3p25.3, has been reported to be a novel tumour suppressor gene in several cancers, [10] [11] [12] but its role and mechanism of action in CRC development remain to be elucidated.
In this study, we observed that LINC00312 is underexpressed both in CRC tissues and in cell lines. LINC00312 overexpression suppressed growth, migration and invasion of CRC cells in vitro and attenuated tumour proliferation and metastasis in vivo. Furthermore, we found that LINC00312 inhibits the progression of CRC by modulating miR-21-PTEN signalling. Our work provides evidence of a cross-talk between LINC00312 and miR-21 and suggests that LINC00312 may serve as a possible new target for the treatment of CRC. 
| MATERIALS AND METHODS

| Collection of CRC samples
| Cell migration and invasion assays
These assays were performed in a transwell chamber (8-μm 
| The luciferase reporter assay
The theoretical binding sequence for miR-21 in the LINC00312 gene and its mutant sequence were cloned into the psiCHECK-2 vector 3 | RESULTS
| In vivo proliferation and metastasis assays
| LINC00312 was found to be down-regulated in CRC
SYBR green qRT-PCR was first carried out to determine LINC00312 levels in four human CRC cell lines (SW480, HT29, SW620, and LoVo) and in NCM460, the normal colon epithelial cell line. All four CRC cell lines showed notably reduced levels of LINC00312, whereas NCM460 cells expressed high levels of LINC00312 ( Figure 1A) . Furthermore, we detected LINC00312 in CRC tissues and adjacent non- These data suggested that LINC00312 might act as a tumour suppressor in CRC.
| LINC00312 directly interacts with miR-21
To further uncover the molecular mechanism by which LINC00312 exerts its biological function in CRC, we performed bioinformatic analysis by different computational methods: miRanda and miRcode. Among the predicted miRNAs, we were particularly interested in miR-21 because of its stimulatory effect on cancer cell proliferation and invasion. 16 The predicted binding Figure 3C ). We then constructed the luciferase reporter vectors containing a wild-type (wt) or mutated (mut) miR-21-binding site in LINC00312 ( Figure 3A) . The results of dual-luciferase reporter assays revealed that miR-21 repressed the luciferase activity of the LINC00312-wt reporter vector, but had no effect on the LINC00312-mut vector ( Figure 3D ). Furthermore, there was a statistically significant inverse correlation between the levels of miR-21 and LINC00312 among CRC tissue samples (Figure 3E ). These data indicated that LINC00312 is a direct target of miR-21.
| The miR-21-PTEN axis is involved the tumour-suppressive effects of LINC00312
After the finding that LINC00312 is a target of miR-21, the role of miR-21 in LINC00312-driven inhibition of CRC progression was still unclear. We transfected miR-21 mimic into LINC00312-overexpressing SW620 and LoVo cells. The results showed that miR-21 mimic strongly attenuated LINC00312-induced inhibitory effects on CRC cell proliferation and invasion ( Figure 4A ,B), indicating that miR-21 plays a crucial role in LINC00312-induced antitumour effects on CRC cells.
It has been found that miR-21 may promote CRC cell proliferation and invasion by down-regulating PTEN protein expression. 15, 17 Here, our results confirmed that miR-21 significantly reduced PTEN levels in SW620 and LoVo cells by directly targeting its 3′UTR 
| DISCUSSION
In this study, we demonstrated that LINC00312 is down-regulated in human CRC tissues and cell lines. Overexpression of Recent studies showed that LINC00312 is associated with several cancers. 
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F I G U R E 5 LINC00312 suppressed tumour growth and metastasis in nude mice. A, A representative photograph of tumour formation: LINC00312-overexpressing SW620 cells were subcutaneously injected into nude mice; data were collected for up to 30 days. The growth curves of tumour volumes (B) and weight (C) are depicted. Levels of LINC00312 (D) and miR-21 (E) in xenograft tumour tissues as determined by qRT-PCR. F, Western blot analyses of PTEN, p-AKT and AKT in LINC00312 overexpressing and control xenograft tumour tissues. G, LINC00312-overexpressing SW620 cells were injected into nude mice through the spleen to evaluate the liver metastatic potential of the cells. After 6 weeks, the livers were sectioned for examination of tumour metastasis by H&E staining. H, The number of metastatic liver nodules per mouse. Data are presented as mean ± SD. *P < 0.05, **P < 0.01
